So given what you're both saying this Need for Speed and that this is not an Apples to Apples comparison. How should we look at the JJ numbers in the context of the other EU ASR emergency use authorization like help me tease it apart since it's still kind of hard to evaluate giving all the mixed news and Buzz out there
by that measure a 50% reduction in symptomatic illness all of the vaccines that have received emergency use authorization. Thus far have far exceeded that Benchmark. So Jay and Jay was in the low to mid 70s. Moderna and visor were much higher. They were in the mid-90s. So they all far exceeded the original sort of threshold Benchmark that was set up for emergency use authorization.